FDA rehires staff to its medical devices division
NY, Zyn and FDA
· 3d · on MSN
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
· 3d
Ozempic and Wegovy are no longer in shortage, FDA says
Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.
Nuts Recall Update
· 3d · on MSN
Nuts Recall Update as FDA Sets Risk Level
· 4d · on MSN
The FDA Set This Recalled Pancake And Waffle Mix To Its Highest Risk Level. Here's What To Know.
Nut recall set at highest FDA level
A batch of recalled Wegmans nuts has been issued a Class II risk classification by the U.S. Food and Drug Administration (FDA). Newsweek reports United Natural Trading Inc. has issued a voluntary recall for Wegmans organic dry roasted salted almonds in January because they were labeled incorrectly as cashews on the back.
The Trump administration had directed health agencies to place a notice condemning “gender ideology” on health webpages that had been earlier taken down.
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday.
Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 treatment for eye disorders. The treatment is a biosimilar that could compete with Regeneron Pharmaceuticals’ Eylea.
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to a government document scheduled to be published in the Federal Register on Tuesday.
Mirum, FDA and Pharmaceuticals
· 3d
US FDA approves Mirum Pharma's genetic disorder drug
FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease
The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX,
FDA approves Mirum treatment for cerebrotendinous xanthomatosis
The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first
The FDA late Friday started reversing termination notices for some employees that were laid off, informing workers to return to work after mass firings a week ago.
Attorney Kyle Diamantas is expected to be announced as the new deputy commissioner for human foods at the US Food and Drug Administration following his predecessor’s resignation earlier this week, sources familiar with the decision said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results